학술논문

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium
Document Type
Article
Source
In European Journal of Cancer July 2017 79:238-246
Subject
Language
ISSN
0959-8049